Overview of intestinal ischemia in adult
Executive Summary
Intestinal ischemia is a critical medical condition caused by any process that reduces blood flow to the small or large intestine, including arterial occlusion, venous occlusion, or arterial vasospasm. The consequences can be catastrophic, leading to sepsis, bowel infarction, and death, making rapid diagnosis imperative. The classic clinical presentation is "abdominal pain out of proportion to the physical examination," a key indicator that should raise a high index of suspicion, as physical findings may be minimal in the early stages.
The primary causes of mesenteric ischemia (affecting the small intestine) are mesenteric arterial embolism (50%), mesenteric arterial thrombosis (15-25%), nonocclusive mesenteric ischemia (NOMI) from low-flow states (20-30%), and mesenteric venous thrombosis (5%). Diagnosis relies heavily on advanced imaging, with multidetector CT angiography (CTA) being the recommended initial test due to its high sensitivity (93.3%) and specificity (96%).
Management goals focus on rapidly restoring intestinal blood flow, providing hemodynamic support, and treating the specific underlying etiology. Initial steps include fluid resuscitation, anticoagulation, and broad-spectrum antibiotics. Definitive treatment varies by cause and may include surgical embolectomy, endovascular revascularization, thrombolysis, or intra-arterial vasodilator infusion. Despite advances, acute mesenteric ischemia carries a high mortality rate, which can exceed 60 percent.
1. Definition and Classification
Intestinal ischemia is defined by insufficient blood flow to the intestine. The condition is classified based on the time course of onset (acute or chronic), the degree of blood flow compromise, the affected intestinal segment, and the underlying pathophysiology.
Mesenteric Ischemia: Refers to ischemia affecting the small intestine.
Colonic Ischemia: Refers to ischemia affecting the large intestine.
Splanchnic (Visceral) Ischemia: A broader term encompassing ischemia of the intestine as well as other abdominal organs like the liver, spleen, or kidneys.
The major classifications of intestinal ischemia are detailed below.
2. Etiologies and Pathophysiology
The etiologies of mesenteric ischemia are diverse, with arterial embolism being the most frequent cause. The intestine possesses a robust collateral circulation that can protect against transient perfusion deficits; however, prolonged reduction in blood flow leads to vasoconstriction and eventual bowel injury.
Major Etiologies of Mesenteric Ischemia
Anatomic and Physiologic Considerations
Vascular Supply: The intestines are primarily supplied by the superior mesenteric artery (SMA), inferior mesenteric artery (IMA), and celiac artery. The SMA and IMA have extensive collateral connections, such as the marginal artery of Drummond and the arc of Riolan.
Watershed Areas: Certain areas are at higher risk for ischemia due to weaker collateral circulation. These include:
Splenic Flexure (Griffiths' point): The junction between the SMA and IMA territories.
Rectosigmoid Junction (Sudeck's point): The junction between the IMA and superior rectal artery territories.
Reperfusion Injury: Restoring blood flow after a period of ischemia can paradoxically cause further tissue damage. This complex process involves the release of free radicals and toxic byproducts, leading to inflammation and potentially multisystem organ failure.
3. Key Risk Factors
Intestinal ischemia is associated with any condition that reduces perfusion to the intestine or predisposes to embolism, thrombosis, or vasoconstriction.
Cardiac Disease: Conditions that promote thrombus formation are major risk factors for embolic ischemia. These include atrial fibrillation, valvular disease, ventricular aneurysm, and poor cardiac function. Low cardiac output is a primary risk factor for NOMI.
Aortic Surgery and Instrumentation: Aortic manipulation during cardiac catheterization, aortography, or surgery can dislodge intraluminal thrombus or atherosclerotic debris, causing atheroembolism.
Peripheral Artery Disease: Atherosclerotic occlusive disease of the celiac artery, SMA, or IMA is the primary risk factor for chronic mesenteric ischemia and acute-on-chronic arterial thrombosis.
Hemodialysis: Can lead to low-flow states and nonocclusive intestinal ischemia.
Acquired and Hereditary Thrombotic Conditions: Up to 75% of patients with mesenteric venous thrombosis have an inherited thrombotic disorder. Other hypercoagulable states (e.g., from malignancy, surgery, or COVID-19) also increase risk.
Vasoconstrictive Medications: Various medications and illicit drugs have been implicated in the development of NOMI.
Hypovolemia: Reduced circulating blood volume, such as from dehydration during extreme exercise, leads to vasoconstriction and can cause intestinal ischemia.
Inflammation and Infection: Systemic inflammation or intra-abdominal infection can lead to mesenteric venous thrombosis. Vascular disorders like vasculitis can also predispose to ischemia.
Segmental Ischemia: Mechanical issues like bowel strangulation due to external hernias, bowel volvulus, or adhesions can cause focal ischemia.
4. Clinical Presentation
The clinical features of intestinal ischemia vary depending on the etiology and severity. A careful history and a high index of suspicion are critical for diagnosis.
Abdominal Pain
Abdominal pain is the most common presenting symptom. The classic clinical description for acute intestinal ischemia is "abdominal pain out of proportion to the physical examination."
Acute Arterial Embolism: Pain is typically sudden, severe, and periumbilical.
Acute Arterial Thrombosis: Patients often have antecedent symptoms of chronic mesenteric ischemia, such as postprandial abdominal pain, food aversion, and weight loss.
Mesenteric Venous Thrombosis: Pain is often more insidious, with a waxing and waning course over a period of time before a diagnosis is established.
Nonocclusive Ischemia (NOMI): The severity and location of pain are more variable and may be overshadowed by the patient's underlying critical illness.
Colonic Ischemia: Typically presents with a rapid onset of mild abdominal pain, often on the left side, followed by rectal bleeding or bloody diarrhea within 24 hours.
Chronic Mesenteric Ischemia: Characterized by recurrent postprandial abdominal pain, leading to a fear of eating ("food fear") and significant weight loss.
Physical Examination and Key Differences
The abdominal examination may be surprisingly benign early in the course of acute mesenteric ischemia. As bowel infarction progresses, signs of peritonitis (rebound tenderness, guarding), abdominal distension, and shock develop, indicating a deteriorating clinical course.
Comparison of Acute Small Bowel vs. Acute Colonic Ischemia
5. Diagnostic Approach
Rapid diagnosis is essential to reduce the potential for intestinal infarction. The diagnostic process is guided by clinical suspicion and advanced imaging.
Laboratory Studies
Laboratory findings are nonspecific, and normal lab values do not exclude acute mesenteric ischemia. Abnormalities may bolster suspicion but should not delay imaging.
L-lactate: An elevated serum lactate level has a pooled sensitivity of 86% but a pooled specificity of only 44%.
D-dimer: A pooled sensitivity of 96% for acute mesenteric ischemia has been reported, but with a low pooled specificity of 40%.
Other findings: May include marked leukocytosis, hemoconcentration (elevated hematocrit), and metabolic acidosis.
Imaging
Advanced imaging is the cornerstone of diagnosis for most forms of intestinal ischemia.
Computed Tomographic (CT) Angiography: Multidetector CT angiography is the recommended initial test for most patients with clinical features suggestive of intestinal ischemia. It should be performed without oral contrast, which can obscure the mesenteric vessels.
Accuracy: Pooled data from six studies showed a sensitivity of 93.3% and a specificity of 96% for diagnosing acute mesenteric ischemia.
Findings: CT can identify arterial occlusion, mesenteric venous thrombosis, and secondary signs of bowel injury such as bowel wall thickening, pneumatosis intestinalis (air in the bowel wall), and portomesenteric venous gas.
Magnetic Resonance (MR) Angiography: An alternative to CT, particularly for patients with an allergy to iodinated contrast. It may be more sensitive for the diagnosis of mesenteric venous thrombosis.
Conventional Arteriography: Catheter-based arteriography is still recommended if the diagnosis remains uncertain after CT. It allows for both diagnosis and potential therapeutic intervention (e.g., infusion of vasodilators).
Plain Abdominal Radiographs: Are relatively nonspecific and may be normal in more than 25% of patients. They are not sufficient to rule out the diagnosis.
Colonoscopy: Is often required to establish or confirm the diagnosis of ischemic colitis.
6. Management and Treatment Principles
The goal of treatment is to restore intestinal blood flow as rapidly as possible after initial supportive management. Treatment strategies are tailored to the specific etiology.
Initial Management
Hemodynamic Support: Fluid resuscitation and monitoring are crucial.
Anticoagulation: Systemic anticoagulation is recommended to prevent thrombus formation and propagation, unless the patient is actively bleeding.
Antibiotics: Broad-spectrum antibiotics are recommended for patients with acute mesenteric and colonic ischemia.
Pain Control: Pain should be managed judiciously, typically with parenteral opioids.
Avoid Vasoconstrictors: Agents that can exacerbate mesenteric ischemia, such as many vasopressors and digitalis, should be avoided. Dobutamine, low-dose dopamine, or milrinone are preferred.
Gastrointestinal Decompression: May be required via a nasogastric tube.
Treatment of Specific Etiologies
Abdominal Exploration
Surgical exploration (laparotomy) should not be delayed in patients with suspected intestinal infarction, peritonitis, or bowel perforation, regardless of the etiology.
7. Outcomes
The prognosis for intestinal ischemia is highly dependent upon the underlying cause and the timeliness of diagnosis and treatment.
Mortality: Acute mesenteric ischemia is associated with very high mortality rates, which can exceed 60 percent.
Operative Mortality: Even among patients who undergo surgery, the pooled operative mortality rate for acute mesenteric ischemia is 47 percent.
Survivors: Patients who survive an acute event are likely to face complications related to the underlying condition that predisposed them to intestinal ischemia.
